Global X Genomics & Biotechnology ETF (GNOM) Holdings $9.83 -0.21 (-2.09%) Closing price 02/21/2025 03:50 PM EasternExtended Trading$9.83 0.00 (0.00%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartHoldingsOptions ChainOwnershipRatingsShort InterestTrends Top 41 GNOM HoldingsRankCompanyCurrent PriceWeightShares Held1NTRANatera$162.31-3.5%6.40%24,2842VCYTVeracyte$39.18-4.6%5.42%88,7533BNTXBioNTech$120.01+1.8%4.91%25,9464AAgilent Technologies$135.33-1.1%4.56%21,6605BEAMBeam Therapeutics$30.43-8.2%4.31%97,7186TECHBio-Techne$64.92-0.9%4.28%41,5397ARWRArrowhead Pharmaceuticals$19.90-5.1%4.26%144,5878CRSPCRISPR Therapeutics$47.91-5.0%4.20%62,5999QGENQiagen$39.52+2.5%4.11%66,49110BMRNBioMarin Pharmaceutical$68.25-0.7%4.09%41,142 Get the Latest News and Ratings for GNOM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 11ALNYAlnylam Pharmaceuticals$250.59-0.2%3.99%9,75512SRPTSarepta Therapeutics$106.28-2.0%3.74%22,17913LEGNLegend Biotech$39.70+2.0%3.68%65,52514RAREUltragenyx Pharmaceutical$42.59-4.2%3.53%52,65015RNAAvidity Biosciences$31.12-4.3%3.23%63,42516ILMNIllumina$94.20-3.1%3.16%20,15217Genscript Biotech CorporationN/A3.13%1,428,31818GILDGilead Sciences$109.95-0.1%2.70%16,49519MYGNMyriad Genetics$14.19-5.3%2.69%119,13320MRNAModerna$35.53+5.3%2.66%53,93121CDNACareDx$22.29-4.7%2.58%67,27222TXG10x Genomics$10.90-5.7%2.50%135,83323VRTXVertex Pharmaceuticals$484.24+0.8%2.16%3,03324NTLAIntellia Therapeutics$12.17-0.7%2.02%136,03525RCKTRocket Pharmaceuticals$10.47-3.7%1.78%114,26926VIRVir Biotechnology$9.57-2.3%1.78%120,15227QUREuniQure$12.84-0.9%1.25%61,35428MRVIMaravai LifeSciences$4.11+4.1%1.02%160,15329VERVVerve Therapeutics$7.28-7.0%1.01%85,09830PACBPacific Biosciences of California$1.54-6.1%0.81%353,34531FLGTFulgent Genetics$16.46-1.0%0.70%26,88232SANASana Biotechnology$3.01-1.6%0.70%161,95733RGNXREGENXBIO$7.27-1.2%0.68%60,59834SGMOSangamo Therapeutics$1.07-4.5%0.48%264,78035ALLOAllogene Therapeutics$2.17-4.0%0.40%183,65736TSVT2seventy bio$2.61-2.6%0.25%63,94837CRBUCaribou Biosciences$1.31-7.1%0.22%109,40038CashN/A0.22%142,64339EDITEditas Medicine$1.92-7.0%0.21%108,41040LYELLyell Immunopharma$0.70+6.2%0.16%182,203Here’s how you could profit from Elon’s NVIDIA partnership (Ad)"Elon's #1 AI Stock" SET TO SOAR Forget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful. After all, ChatGPT just works online... While Elon's AI works in the real world. Get all the details here >>>41SCLXScilex$0.33-1.7%0.00%226,071 Geographic ExposureUnited States86.7%Switzerland4.7%Netherlands3.8%Cayman Islands3.4%Currency ExposureUSD78.0%HKD3.4%Sector ExposureHealth Care65.5%Energy1.0%Industry ExposureBiotechnology32.7%Health Care Equipment & Supplies22.7%Health Care Providers & Services6.8%Life Sciences Tools & Services3.4%Renewable Energy1.0%SubIndustry ExposureBiotechnology32.0%Life Sciences Tools & Services23.8%Health Care Services6.8%Health Care Equipment2.3%Renewable Energy Equipment1.0% Related Companies and Tools Related Companies LFGY Holdings CANC Holdings MDCP Holdings UFO Holdings HRTS Holdings ZAP Holdings VPN Holdings FDCF Holdings AGNG Holdings TARK Holdings This page (NASDAQ:GNOM) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNOM Stock Alerts